title: Cost of Treatment for Relapsed/Refractory Multiple Myeloma.
authors.forename: Safiya
authors.initials: S
authors.lastname: Abouzaid
authors.forename: Craig
authors.initials: C
authors.lastname: Gibson
authors.affiliation: Celgene Corporation, Summit, NJ.
authors.forename: Yasir
authors.initials: Y
authors.lastname: Nagarwala
references.citation: Curr Med Res Opin. 2015 Jun;31(6):1105-15
references.pmid: 25785551
references.citation: Lancet Oncol. 2014 Oct;15(11):1195-206
references.pmid: 25242045
references.citation: Clin Lymphoma Myeloma Leuk. 2011 Feb;11(1):38-43
references.pmid: 21273172
references.citation: Leukemia. 2012 Jan;26(1):149-57
references.pmid: 21799510
references.citation: Lancet Oncol. 2013 Oct;14(11):1055-66
references.pmid: 24007748
references.citation: Am Health Drug Benefits. 2015 Jun;8(4):204-15
references.pmid: 26157542